相关实验视频
Updated: Jul 8, 2025

07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
85.0K
HIF-1α/METTL1/m7G轴参与CRC对低氧反应的反应
Shuyi Mi1, Shangwen Cai1, Meng Xue1
1Department of Gastroenterology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China; Institute of Gastroenterology, Zhejiang University, Hangzhou, China.
Biochemical and biophysical research communications
|December 20, 2023
概括
缺氧可以通过抑制METTL1转录通过HIF-1α.降低N7-甲基黄素 (m7G) 在结直肠癌 (CRC) 中的RNA甲基化. 这项研究揭示了在低氧条件下CRC发展的关键机制.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 缺氧和缺氧诱导因子 (HIF) -1α是结直肠癌 (CRC) 的确立驱动因素.
- HIF-1α 影响表观转录组修饰,但其在CRC中缺氧下RNA甲基化中的作用尚未完全理解.
研究的目的:
- 研究CRC中低毒条件下RNA甲基化是如何改变的.
- 阐明调控机制,特别是HIF-1α在这些变化中的作用.
主要方法:
- 使用液体染色学-并联质谱法对mRNA和tRNA修饰的量化.
- 改变的修改的验证和RNA修改调节酶的测量.
- 通过促进剂试验,siRNA和染色体免疫沉 (ChIP) 调查HIF-1α在METTL1表达中的作用.
主要成果:
- 在低氧状态下,tRNA修饰的变化比mRNA修饰更为一致.
- 在tRNA中的N7-甲基黄氨酸 (m7G) 修饰显著下降.
- HIF-1α直接与METTL1促进体结合,抑制其转录,导致METTL1的表达减少.
结论:
- 在缺氧下,CRC细胞表现出由于HIF-1α介导的METTL1转录抑制而减少的m7GtRNA修饰.
- 这一途径代表了在低氧应激下CRC进展的重要机制.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K

